Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice

Transplantation

Volumn 75, Issue 8, 2003, Pages 1415-1422

  Lee IV, Major K ^a   Huang, Xiaolun ^a   Jarrett, Beth P ^a   Moore, Daniel J ^a   Desai, Niraj M ^a   Lian, Moh Moh ^a   Markmann, Joseph W ^a   Deng, Shaoping ^a   Frank, Adam ^a   Singer, Andrew ^a   Velidedeoglu, Ergun ^a   Caton, Andrew J ^b   Markmann, James F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; EPITOPE; FLUORESCENT DYE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VIRUS HEMAGGLUTININ;

ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SKIN TRANSPLANTATION; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE SUSCEPTIBILITY; GRAFT REJECTION; HEART TRANSPLANTATION; HEMAGGLUTININS, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOLOGIC MEMORY; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037469063     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000064296.65628.6C     Document Type: Conference Paper

References (22)

1. Jones N, Turvey S, van Maurik A, et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001; 166: 2824.
2. Nash J, Peters M, Bell P. Comparative survival of pancreatic islets, heart, kidney, and skin allografts in rats, with and without enhancement. Transplantation 1977; 24: 70.
3. Naji A, Barker C, Silvers W. Relative vulnerability of isolated pancreatic islets, parathyroid, and skin allografts to cellular and humoral immunity. Transplant Proc 1979; 11: 560.
4. Zhang Z, Zhu L, Quan D, et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996; 62: 1267.
5. Jones N, van Maurik A, Hara M, et al. T cell activation, proliferation, and memory following cardiac transplantation in vivo. Ann Surg 1999; 229: 570.
6. Zelenika D, Adams E, Mellor A, et al. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: No requirement for CD8+ T cells or B cells. J Immunol 1998; 161: 1868.
7. Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
8. Bishop D, Chan S, Li W, et al. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993; 56: 892.
9. Rosenberg A, Katz S, Singer A. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia-epidermal cells. J Immunol 1989; 143: 2452.
10. Kirberg J, Baron A, Jakob S, et al. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 1994; 180: 2511.
11. Caton A, Schwartzentruber J, Kuhl A, et al. Activation and negative selection of functionally distinct subsets of antibody-secreting cells by influenza hemagglutinin as a viral and neo-self antigen. J Exp Med 1996; 183: 13.
12. Shih F, Cerasoli D, Caton A. A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self-peptide in HA transgenic mice. Int Immunol 1997; 9: 249.
13. Billingham R, Medawar P. The technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
14. Corry R, Winn H, Russell P. Primarily vascularized allografts of hearts in mice: The role of H-2D, H-2K and non H-2 antigens in rejection. Transplantation 1973; 16: 343.
15. Trani J, Moore D, Jarrett B, et al. CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance. J Immunol 2003; 170: 279.
16. Faustman D, Heuptfeld V, Davie M, et al. Murine pancreatic beta cells express H-2K and H-2D but not Ia antigens. J Exp Med 1980; 151: 1562.
17. Markmann J, Jacobson J, Kiumura H, et al. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation 1989; 48: 478.
18. Markmann JF, Bassiri H, Desai NM, et al. Indefinite survival of MHC class I deficient murine pancreatic islet allografts. Transplantation 1992; 54: 1085.
19. Desai NM, Bassiri H, Kim J, et al. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice. Transplantation 1993; 55: 718.
20. Campos L, Naji A, Deli BC, et al. Survival of MHC deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.
21. Kearney E, Pape K, Loh D, et al. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994; 1: 327.
22. Lyons A, Parish C. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1990; 171: 131.